Vitek 2 Gram Positive Susceptibility Test Cards (AST-P645 REF 419602), 20 cards/kit. Product Usage: The VITEK 2 Gram Positive Susceptibility Card is intended for use with VITEK 2 Systems in clinical laboratories as an in vitro test to determine the susceptibility of Staphylococcus spp., Enterococcus spp., and S. agalactiae to antimicrobial agents when used as instructed in the Product Information manual.
Published May 18, 2016 · Recall initiated: February 24, 2016
Summary
FDA records medical device Class I recall Z-1646-2016, published May 18, 2016 and initiated February 24, 2016. Recalling firm: Biomerieux Inc; Status: Terminated; Reported quantity: 1,524 kits; Lot: Lots 745363420 exp. 11/25/16 and 745375920 exp. 3/30/17. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Product insert fails to identify performance limitation related to EUCAST breakpoints for Teicolplanin.
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Biomerieux Inc
- Distributor
- Foreign distribution in the countries of Czech Republic, Hong Kong (China), Hungary, Japan, Poland, South Africa, Switzerland, and Turkey.
- Lot
- Lots 745363420 exp. 11/25/16 and 745375920 exp. 3/30/17.
- Risk classification
- Class I
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAVITEK 2 AST-N461 TEST KIT, GRAM NEGATIVE SUSCEPTIBILITY TESTING - AUTOMATED, Reference Number 424811September 30, 2026
- FDAVITEK 2 AST-N447 TEST KIT Product reference 424620July 15, 2026
- FDAVITEK 2 Gram-negative Susceptibility Cards Containing o Polymyxin B (pb02n) o Ceftazidime/avibactam (cza02n) oFebruary 11, 2026
- FDAVITEK 2 - AST Test kits (in vitro diagnostic test cards for antimicrobial susceptibility): a) AST-N334, REFMay 1, 2024
- FDAVitek 2 Gram Positive Susceptibility Test Cards (AST-P640 REF 418579), 20 cards/kit. Product Usage: The VITEKMay 18, 2016
- FDADimension Assays: Direct HDL Cholesterol (AHDL)May 18, 2016
Questions about this recall
Was Vitek 2 Gram Positive Susceptibility Test Cards (AST-P645 REF 419602), 20 cards/kit. Product Usage: The VITEK 2 Gram Positive Susceptibility Card is intended for use with VITEK 2 Systems in clinical laboratories as an in vitro test to determine the susceptibility of Staphylococcus spp., Enterococcus spp., and S. agalactiae to antimicrobial agents when used as instructed in the Product Information manual. recalled?
Yes. FDA published recall Z-1646-2016 on May 18, 2016. Reported hazard: Product insert fails to identify performance limitation related to EUCAST breakpoints for Teicolplanin.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail